Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 11-12-2025 | 09-30-2025 | 10-Q | |
| 2 | 07-28-2025 | 06-30-2025 | 10-Q | |
| 3 | 05-12-2025 | 03-31-2025 | 10-Q | |
| 4 | 03-26-2025 | 12-31-2024 | 10-K |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com...
Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesi...
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscapeCom...
Pfizer plans to sell its remaining BioNTech stake through a $508 million block trade, ending a profitable Covid-19 vaccine part...
Metsera (NASDAQ:MTSR) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.69) by ...
Novo Nordisk shares are trading higher on Tuesday. The company recently lost its bidding war for Metsera Inc.
